← Back to Clinical Trials
Recruiting NCT02635022

NCT02635022 Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02635022
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Osteoporosis
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2015-09
Primary Completion 2026-12

Trial Parameters

Condition Osteoporosis
Sponsor National Taiwan University Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 50 Years
Max Age N/A
Start Date 2015-09
Completion 2026-12

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Aims: (1) to Establish the FLS services at the National Taiwan University Hospital Jinshan Branch. (2) To establish a anti-osteoporosis medication management service at Jinshan Branch. Method: From Aug., 2015, a fracture liaison services (FLSs) following the 13 'Capture the Fracture Best Practice Standards' were implemented at the National Taiwan University Hospital Jinshan Branch health care system. The Jinshan Branch program enrolled patient with 1) new hip fracture 2) newly identified vertebral fractures (radiological or clinical) from both inpatients and outpatients. At the same time, a osteoporosis medication management service is also establish as a complement of FLS to enroll patients on antiosteoporosis medications (AOMs) but not necessary with fracture. Participating physicians will select those eligible for services and refer to study coordinators. Study coordinators will conduct baseline assessments on osteoporosis/fracture risks, record medical conditions, AOMs, provide educations on osteoporosis, fracture, sarcopenia, fall, medications, nutrition, and exercise. They also arrange return clinic visit, telephone reminder and follow up for patients, and communicate with providers on regular bases. During the whole study period, the investigators planed to enroll 200 patients (with or without fracture). Each patient would be assessed at baseline, and every 4 months last for two years.

Eligibility Criteria

Inclusion Criteria: * Age \>=50 and one of the below * New hip fracture in orthopedic ward * Newly identified radiographic vertebral fractures from plan films in geriatric ward or clinical vertebral fractures in outpatient clinics * Newly prescribed with AOMs * Recent change of AOMs * Poor adherence to AOMs * Participating physicians feel that the service will benefit the patient in overall osteoporosis and medication managements. Exclusion Criteria: * Life expectancy less than 2 years or can't be assessed for communication problems * Atypical fractures * Patient in other medication clinical trials * Unwilling to accept the assessment and treatment

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology